High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia

Splenectomy increase the risk of severe and fatal infections, however the risk of Plasmodium vivax malaria is unknown. We quantified the Plasmodium species-specific risks of malaria and other outcomes following splenectomy in patients attending a hospital in Papua, Indonesia.Records of all patients...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Kho, S, Andries, B, Poespoprodjo, JR, Commons, RJ, Shanti, PAI, Kenangalem, E, Douglas, NM, Simpson, JA, Sugiarto, P, Anstey, NM, Price, RN
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Oxford University Press 2018

Gelijkaardige items

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
door: Thriemer, K, et al.
Gepubliceerd in: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
door: Setyadi, A, et al.
Gepubliceerd in: (2019)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
door: Douglas, NM, et al.
Gepubliceerd in: (2017)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
door: Kenangalem, E, et al.
Gepubliceerd in: (2017)

Evaluation of splenic accumulation and colocalization of immature reticulocytes and Plasmodium vivax in asymptomatic malaria: A prospective human splenectomy study
door: Kho, S, et al.
Gepubliceerd in: (2021)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
door: Douglas, NM, et al.
Gepubliceerd in: (2020)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
door: Dini, S, et al.
Gepubliceerd in: (2020)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
door: Douglas, N, et al.
Gepubliceerd in: (2014)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
door: Commons, RJ, et al.
Gepubliceerd in: (2018)

Early and late mortality after malaria in young children in Papua, Indonesia
door: Patriani, D, et al.
Gepubliceerd in: (2019)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
door: Price, RN, et al.
Gepubliceerd in: (2018)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
door: Rahmalia, A, et al.
Gepubliceerd in: (2019)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
door: Lampah, D, et al.
Gepubliceerd in: (2011)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
door: Price, R, et al.
Gepubliceerd in: (2007)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a rising burden of Plasmodium vivax malaria
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2019)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
door: Tjitra, E, et al.
Gepubliceerd in: (2007)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
door: Leonardo, L, et al.
Gepubliceerd in: (2022)

Estimating the proportion of plasmodium vivax recurrences caused by relapse: A systematic review and meta-analysis
door: Commons, RJ, et al.
Gepubliceerd in: (2020)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
door: Tjitra, E, et al.
Gepubliceerd in: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
door: Tjitra, E, et al.
Gepubliceerd in: (2008)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
door: Karyana, M, et al.
Gepubliceerd in: (2008)

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
door: Anstey, N, et al.
Gepubliceerd in: (2012)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
door: Pava, Z, et al.
Gepubliceerd in: (2020)

The anaemia of Plasmodium vivax malaria.
door: Douglas, N, et al.
Gepubliceerd in: (2012)

Plasmodium vivax in the era of the shrinking P. falciparum map
door: Price, RN, et al.
Gepubliceerd in: (2020)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
door: Oyong, DA, et al.
Gepubliceerd in: (2018)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
door: Kho, S, et al.
Gepubliceerd in: (2016)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
door: Karyana, M, et al.
Gepubliceerd in: (2007)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
door: Devine, A, et al.
Gepubliceerd in: (2017)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2008)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
door: Rahmalia, A, et al.
Gepubliceerd in: (2023)

Therapeutic response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax nine years after its introduction in Southern Papua, Indonesia
door: Poespoprodjo, JR, et al.
Gepubliceerd in: (2018)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
door: Price, R, et al.
Gepubliceerd in: (2005)

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.
door: Douglas, N, et al.
Gepubliceerd in: (2013)

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.
door: Douglas, N, et al.
Gepubliceerd in: (2013)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
door: Kenangalem, E, et al.
Gepubliceerd in: (2019)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
door: Yilma, D, et al.
Gepubliceerd in: (2023)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
door: Yeo, T, et al.
Gepubliceerd in: (2010)

Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
door: Lampah, D, et al.
Gepubliceerd in: (2015)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
door: Ratcliff, A, et al.
Gepubliceerd in: (2007)